Incannex Healthcare Inc.
IXHL
$0.39
-$0.03-6.72%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -- | -- | -- | -- |
| SG&A Expenses | -29.11% | -45.19% | -32.61% | 50.26% | 117.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.99% | -24.82% | -22.75% | 593.96% | 54.28% |
| Operating Income | -23.22% | 24.82% | 22.98% | -584.65% | -53.99% |
| Income Before Tax | -391.42% | 34.21% | -12.46% | -646.56% | -54.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -389.13% | 34.21% | -12.46% | -646.56% | -54.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -389.13% | 34.21% | -12.46% | -646.56% | -54.79% |
| EBIT | -23.22% | 24.82% | 22.98% | -584.65% | -53.99% |
| EBITDA | -23.86% | 25.63% | 25.21% | -586.97% | -52.55% |
| EPS Basic | -0.29% | 46.82% | -1.27% | -572.21% | -44.18% |
| Normalized Basic EPS | 0.76% | 60.13% | -1.26% | -571.33% | -43.49% |
| EPS Diluted | -0.29% | 46.82% | -1.27% | -572.21% | -44.18% |
| Normalized Diluted EPS | 0.76% | 60.13% | -1.26% | -571.33% | -43.49% |
| Average Basic Shares Outstanding | 387.74% | 23.68% | 11.03% | 11.15% | 7.34% |
| Average Diluted Shares Outstanding | 387.74% | 23.68% | 11.03% | 11.15% | 7.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |